January 13, 2025 - 02:56
ALAMEDA, Calif., January 12, 2025—Exelixis, Inc. has announced its preliminary unaudited financial results for the fiscal year 2024, alongside financial guidance for the upcoming fiscal year 2025. The company is optimistic about the potential for significant advancements in clinical and regulatory efforts, particularly concerning its cabozantinib franchise.
In 2025, Exelixis plans to focus on executing its clinical programs and anticipates multiple data readouts for zanzalintinib, as well as developments across its diverse pipeline of small molecules and biotherapeutics. The company aims to leverage its existing assets while exploring new opportunities to enhance its market position.
With a clear strategy in place, Exelixis is poised for a year of growth, innovation, and impactful milestones that could shape the future of its therapeutic offerings. The commitment to advancing patient care remains at the forefront of Exelixis's mission as it navigates the challenges and opportunities ahead.
June 25, 2025 - 00:18
Yale's Financial Stability Program Unveils Crisis Management PlaybookThis year marks a significant milestone for the Yale Program on Financial Stability as it wraps up the New Bagehot Project. This ambitious initiative, spanning a decade, has meticulously chronicled...
June 24, 2025 - 04:52
Japan's Foreign Exchange Diplomat Reappointed for Another YearTOKYO - Japan`s leading foreign exchange diplomat, Atsushi Mimura, has been reappointed for a second consecutive year, according to the finance ministry. This decision underscores his significance...
June 23, 2025 - 19:11
Rethinking Finance: A Call for Inclusivity and SustainabilityIn affluent societies, the relationship with money has shifted dramatically, transforming it into a master rather than a servant. This paradigm has far-reaching implications, not only for...
June 23, 2025 - 05:12
NJBIZ Finance Power List: Celebrating the Most Influential Leaders in FinanceThe NJBIZ Finance Power List has unveiled its selection of the most influential leaders in the finance sector for 2025. This prestigious list highlights the professionals who play a critical role...